These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7083508)

  • 41. [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects].
    Assmann I
    Z Gesamte Inn Med; 1985 Jun; 40(11):335-41. PubMed ID: 4036210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propranolol and hyperthyroidism: sequential changes in serum iodothyronine (T4, T3, rT3) concentrations during therapy until clinical remission.
    Pinho MO; Medeiros YS; Rosenthal D; Francalanci CC
    Braz J Med Biol Res; 1983 Jul; 16(2):111-7. PubMed ID: 6652288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of amiodarone on serum T3 and T4 concentrations in hyperthyroid patients treated with propylthiouracil.
    Van Reeth O; Unger J
    Thyroid; 1991; 1(4):301-6. PubMed ID: 1841729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
    J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
    Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
    J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
    Naccarelli GV; Fineberg NS; Zipes DP; Heger JJ; Duncan G; Prystowsky EN
    J Am Coll Cardiol; 1985 Oct; 6(4):814-21. PubMed ID: 3928727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
    Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
    J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of circulating thyroxine serum concentration on hepatic thyroxine deiodinating activity in rats.
    Keck FS; Wolf CF; Pfeiffer EF
    Exp Clin Endocrinol; 1990 Dec; 96(3):269-77. PubMed ID: 2083567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating 3,3', 5'-triiodothyronine (reverse T3) in the human newborn.
    Chopra IJ; Sack J; Fisher DA
    J Clin Invest; 1975 Jun; 55(6):1137-41. PubMed ID: 1133163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reciprocal changes in serum concentrations of 3,3',5-triiodothyronine (T3) in systemic illnesses.
    Chopra IJ; Chopra U; Smith SR; Reza M; Solomon DH
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1043-9. PubMed ID: 812882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of benziodarone on the thyroid hormone levels and the pituitary-thyroid axis.
    Xanthopoulos B; Koutras DA; Boukis MA; Piperingos GD; Kitsopanides J; Souvatzoglou A; Moulopoulos SD
    J Endocrinol Invest; 1986 Aug; 9(4):337-9. PubMed ID: 3491129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of parturition on serum iodothyronine concentrations in fetal sheep.
    Klein AH; Oddie TH; Fisher DA
    Endocrinology; 1978 Oct; 103(4):1453-7. PubMed ID: 744158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction.
    Kabadi UM; Premachandra BN
    Am J Gastroenterol; 1983 Nov; 78(11):750-5. PubMed ID: 6637968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ; Williams DE; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
    Peter T; Hamer A; Mandel WJ; Weiss D
    Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intravenous amiodarone in the therapy of paroxysmal supraventricular tachycardias].
    Storelli A; Andriulo C; Chisena A; De Giorgi M; De Giorgio NA; Gallone V; Guadalupi M; Lupis O; Nadovezza S; Tarentini A
    G Ital Cardiol; 1985 Mar; 15(3):290-7. PubMed ID: 4018468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.